Who
Harold Eugene Brakewood
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Immuneering.
In numbers
- Trades disclosed
- 13
- Buys
- 3
- Sells
- 0
- Bought
- $65K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Mar 2023
- Last trade
- 3 Feb 2026
- Last filed
- 5 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $25K5,250 at $4.76 | filing |
| 16 Jan 2026filed 21 Jan 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $25K5,250 at $4.76 | filing |
| 20 Jun 2025filed 24 Jun 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $4,8071,900 at $2.53 | filing |
| 5 Feb 2025filed 7 Feb 2025 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —165,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —60,500 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,500 at $0.00 | filing |
| 22 Mar 2024filed 25 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $10K3,900 at $2.57 | filing |
| 8 Feb 2024filed 9 Feb 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,500 at $0.00 | filing |
| 31 Mar 2023filed 3 Apr 2023 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.